Which has preferable earnings & valuation, ACONW or CCLDO?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $83.77K N/A N/A N/A N/A CareCloud $128.64M N/A N/A N/A N/A

Is ACONW or CCLDO more profitable?

Company Net Margins Return on Equity Return on Assets Aclarion N/A N/A N/A CareCloud N/A N/A N/A

Which has stronger valuation and earnings, ONMDW or ACONW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OneMedNet $1.46M N/A N/A N/A N/A Aclarion $83.77K N/A N/A N/A N/A

Is ONMDW or ACONW more profitable?

Company Net Margins Return on Equity Return on Assets OneMedNet N/A N/A N/A Aclarion N/A N/A N/A

Which has better valuation & earnings, VSEEW or ACONW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VSee Health $14.46M N/A N/A N/A N/A Aclarion $83.77K N/A N/A N/A N/A

Is VSEEW or ACONW more profitable?

Company Net Margins Return on Equity Return on Assets VSee Health N/A N/A N/A Aclarion N/A N/A N/A

Do analysts prefer ACONW or VEEV?

Veeva Systems has a consensus target price of $284.46, indicating a potential upside of 0.13%. Given Veeva Systems' stronger consensus rating and higher probable upside, analysts plainly believe Veeva Systems is more favorable than Aclarion. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Veeva Systems 1 Sell rating(s) 8 Hold rating(s) 19 Buy rating(s) 0 Strong Buy rating(s) 2.64

Which has preferable valuation and earnings, ACONW or VEEV?

Veeva Systems has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $83.77K N/A N/A N/A N/A Veeva Systems $3.20B 14.44 $908.91M $6.08 46.73

Do analysts recommend ACONW or WAY?

Waystar has a consensus target price of $35.52, suggesting a potential upside of 36.20%. Given Waystar's stronger consensus rating and higher probable upside, analysts plainly believe Waystar is more favorable than Aclarion. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Waystar 1 Sell rating(s) 2 Hold rating(s) 20 Buy rating(s) 3 Strong Buy rating(s) 2.96

Which has stronger earnings & valuation, ACONW or WAY?

Waystar has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $83.77K N/A N/A N/A N/A Waystar $1.10B 4.55 $112.09M $0.70 37.26

Is ACONW or WAY more profitable?

Waystar has a net margin of 11.18% compared to Aclarion's net margin of 0.00%. Waystar's return on equity of 7.03% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion N/A N/A N/A Waystar 11.18% 7.03% 4.75%

Aclarion (ACONW) Competitors

$0.05 +0.01 (+19.75%)

Closing price 09/3/2026 12:48 PM Eastern

Extended Trading

$0.04 -0.01 (-21.09%)

As of 04:00 AM Eastern

Compare

ACONW vs. CCLDO, ONMDW, VSEEW, VEEV, and WAY

Should you buy Aclarion stock or one of its competitors? Aclarion's main competitors and comparable companies include CareCloud (CCLDO), OneMedNet (ONMDW), VSee Health (VSEEW), Veeva Systems (VEEV), and Waystar (WAY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Aclarion compare to CareCloud?

Aclarion (NASDAQ:ACONW) and CareCloud (NASDAQ:CCLDO) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

In the previous week, Aclarion's average media sentiment score of 0.00 equaled CareCloud'saverage media sentiment score.

Company	Overall Sentiment
Aclarion	Neutral
CareCloud	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	N/A	N/A	N/A
CareCloud	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$83.77K	N/A	N/A	N/A	N/A
CareCloud	$128.64M	N/A	N/A	N/A	N/A

Summary

CareCloud beats Aclarion on 1 of the 1 factors compared between the two stocks.

How does Aclarion compare to OneMedNet?

OneMedNet (NASDAQ:ONMDW) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

In the previous week, OneMedNet's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score.

Company	Overall Sentiment
OneMedNet	Neutral
Aclarion	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.46M	N/A	N/A	N/A	N/A
Aclarion	$83.77K	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
OneMedNet	N/A	N/A	N/A
Aclarion	N/A	N/A	N/A

Summary

OneMedNet beats Aclarion on 1 of the 1 factors compared between the two stocks.

How does Aclarion compare to VSee Health?

VSee Health (NASDAQ:VSEEW) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, VSee Health's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score.

Company	Overall Sentiment
VSee Health	Neutral
Aclarion	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	N/A	N/A	N/A	N/A
Aclarion	$83.77K	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	N/A	N/A	N/A
Aclarion	N/A	N/A	N/A

Summary

VSee Health beats Aclarion on 1 of the 1 factors compared between the two stocks.

How does Aclarion compare to Veeva Systems?

Aclarion (NASDAQ:ACONW) and Veeva Systems (NYSE:VEEV) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

88.2% of Veeva Systems shares are held by institutional investors. 10.6% of Veeva Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Veeva Systems has a net margin of 29.34% compared to Aclarion's net margin of 0.00%. Veeva Systems' return on equity of 14.25% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	N/A	N/A	N/A
Veeva Systems	29.34%	14.25%	11.71%

Veeva Systems has a consensus target price of $284.46, indicating a potential upside of 0.13%. Given Veeva Systems' stronger consensus rating and higher probable upside, analysts plainly believe Veeva Systems is more favorable than Aclarion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Veeva Systems	1 Sell rating(s)	8 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.64

Veeva Systems has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$83.77K	N/A	N/A	N/A	N/A
Veeva Systems	$3.20B	14.44	$908.91M	$6.08	46.73

In the previous week, Veeva Systems had 47 more articles in the media than Aclarion. MarketBeat recorded 47 mentions for Veeva Systems and 0 mentions for Aclarion. Veeva Systems' average media sentiment score of 0.76 beat Aclarion's score of 0.00 indicating that Veeva Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Aclarion	Neutral
Veeva Systems	Positive

Summary

Veeva Systems beats Aclarion on 11 of the 11 factors compared between the two stocks.

How does Aclarion compare to Waystar?

Aclarion (NASDAQ:ACONW) and Waystar (NASDAQ:WAY) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment.

Waystar has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$83.77K	N/A	N/A	N/A	N/A
Waystar	$1.10B	4.55	$112.09M	$0.70	37.26

Waystar has a consensus target price of $35.52, suggesting a potential upside of 36.20%. Given Waystar's stronger consensus rating and higher probable upside, analysts plainly believe Waystar is more favorable than Aclarion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Waystar	1 Sell rating(s)	2 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Waystar has a net margin of 11.18% compared to Aclarion's net margin of 0.00%. Waystar's return on equity of 7.03% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	N/A	N/A	N/A
Waystar	11.18%	7.03%	4.75%

In the previous week, Waystar had 13 more articles in the media than Aclarion. MarketBeat recorded 13 mentions for Waystar and 0 mentions for Aclarion. Waystar's average media sentiment score of 0.87 beat Aclarion's score of 0.00 indicating that Waystar is being referred to more favorably in the news media.

Company	Overall Sentiment
Aclarion	Neutral
Waystar	Positive

Summary

Waystar beats Aclarion on 10 of the 10 factors compared between the two stocks.

Get Aclarion News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACONW vs. The Competition

Export

Metric	Aclarion	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$1.76B	$7.26B	$12.73B
Dividend Yield	N/A	4.71%	2.53%	8.86%
P/E Ratio	N/A	21.24	273.30	25.25
Price / Sales	N/A	84.01	618.15	97.66
Price / Cash	N/A	31.87	77.82	52.26
Price / Book	N/A	7.35	12.89	6.14
Net Income	N/A	-$26.60M	$3.47B	$349.01M
7 Day Performance	N/A	-0.13%	0.53%	-0.31%
1 Month Performance	N/A	10.98%	5.64%	0.64%
1 Year Performance	N/A	-15.06%	25.31%	14.83%

Aclarion Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACONW Aclarion	N/A	$0.05 +19.8%	N/A	+24.4%	$0.00	$83.77K	N/A	7	Gap Down
CCLDO CareCloud	N/A	$27.44 flat	N/A	N/A	$0.00	$128.64M	N/A	4,100	Gap Down
ONMDW OneMedNet	N/A	$0.03 -2.6%	N/A	+12.4%	$0.00	$1.46M	N/A	20	Gap Down
VSEEW VSee Health	N/A	$0.02 flat	N/A	N/A	$0.00	$14.46M	N/A	N/A
VEEV Veeva Systems	3.419 of 5 stars	$247.96 +0.0%	$258.08 +4.1%	+4.8%	$40.28B	$3.20B	44.20	7,928	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACONW) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aclarion (ACONW) Competitors